Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-10 | Daniel C. Stanzione, Ph.D., 69, retired from Lucent Technologies Incorporated in 2000 and is President Emeritus of Bell Laboratories and an independent consultant. ... He has been a director of Quest Diagnostics since January 1997, and its Chairman since May 1, 2012. ... Dr. Stanzione has extensive executive experience, including in general management and strategic planning, with multinational corporations operating in complex industries. |
| 2016-04-07 | Daniel C. Stanzione, Ph.D. Chairman 70 1997 President Emeritus, Bell Laboratories AFC GC (Chair) EX (Chair) 414,777 |
| 2017-04-05 | Dr. Stanzione retired from Lucent Technologies Incorporated in 2000 and is President Emeritus of Bell Laboratories and an independent consultant. ... Dr. Stanzione has extensive executive experience, including in general management and strategic planning, with multinational corporations operating in complex industries. ... Audit and Finance Committee: Gary M. Pfeiffer (Chair), Jenne K. Britell, Timothy L. Main, Daniel C. Stanzione, John B. Ziegler ... Governance Committee: Daniel C. Stanzione (Chair), Timothy L. Main, Gary M. Pfeiffer, Timothy M. Ring, Gail R. Wilensky ... Executive Committee: Daniel C. Stanzione (Chair), Gary M. Pfeiffer, Stephen H. Rusckowski ... 2016 Directors Compensation Table: Daniel C. Stanzione 451,472 |
| 2018-04-04 | Dr. Stanzione has been Lead Independent Director since January 1, 2017 and served as Chairman from May 1, 2012 until January 1, 2017. ... Audit and Finance Committee: Daniel C. Stanzione Number of 2017 Meetings: 9 ... Governance Committee: Daniel C. Stanzione (Chair) Number of 2017 Meetings: 4 ... Executive Committee: Daniel C. Stanzione (Chair) Number of 2017 Meetings: 0 ... 2017 Director Compensation Table: Daniel C. Stanzione Fees Earned or Paid in Cash ($) 160,375 Stock Awards ($) 167,965 Total ($) 328,340 |
| 2019-04-03 | Dr. Stanzione retired from Lucent Technologies Incorporated in 2000 and is President Emeritus of Bell Laboratories and an independent consultant. ... Audit and Finance Committee, Governance Committee (Chair), Executive Committee (Chair) ... 2018 Director Compensation Table ... Daniel C. Stanzione 166,000 167,984 333,984 |
Data sourced from SEC filings. Last updated: 2026-03-05